Recent advances in polymeric micelles for anti-cancer drug delivery

Eur J Pharm Sci. 2016 Feb 15:83:184-202. doi: 10.1016/j.ejps.2015.12.031. Epub 2015 Dec 31.

Abstract

Block co-polymeric micelles receive increased attention due to their ability to load therapeutics, deliver the cargo to the site of action, improve the pharmacokinetic of the loaded drug and reduce off-target cytotoxicity. While polymeric micelles can be developed with improved drug loading capabilities by modulating hydrophobicity and hydrophilicity of the micelle forming block co-polymers, they can also be successfully cancer targeted by surface modifying with tumor-homing ligands. However, maintenance of the integrity of the self-assembled system in the circulation and disassembly for drug release at the site of drug action remain a challenge. Therefore, stimuli-responsive polymeric micelles for on demand drug delivery with minimal off-target effect has been developed and extensively investigated to assess their sensitivity. This review focuses on discussing various polymeric micelles currently utilized for the delivery of chemotherapeutic drugs. Designs of various stimuli-sensitive micelles that are able to control drug release in response to specific stimuli, either endogenous or exogenous have been delineated.

Keywords: Anticancer; Block polymer; Cancer therapy; EPR effect; Polymeric micelles; Targeted delivery.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / therapeutic use
  • Drug Delivery Systems*
  • Humans
  • Micelles*
  • Nanoparticles / administration & dosage
  • Nanoparticles / therapeutic use
  • Neoplasms / drug therapy
  • Polymers / administration & dosage*
  • Polymers / therapeutic use

Substances

  • Antineoplastic Agents
  • Micelles
  • Polymers